Complement-induced entry o f membrane-impermeable material into living tumor cells: possibilities for chemotherapy.
D000818:Animals; D002463:Cell Membrane Permeability; D003165:Complement System Proteins; D003561:Cytarabine / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use; D004910:Erythrocyte Membrane / Q000378:metabolism; D006157:Guanosine Monophosphate / Q000031:analogs & derivatives / Q000627:therapeutic use; D006160:Guanosine Triphosphate / Q000031:analogs & derivatives*; D008223:Lymphoma / Q000188:drug therapy*; D051379:Mice; D009994:Osmolar Concentration; D011817:Rabbits; D013395:Sucrose / Q000378:metabolism
D004164:Diphosphonates; D003561:Cytarabine; C004805:5'-guanylylmethylenebisphosphonate; D013395:Sucrose; D006157:Guanosine Monophosphate; D006160:Guanosine Triphosphate; D003165:Complement System Proteins